Why Moderna and Pfizer Beat the Market Today
Moderna (NASDAQ: MRNA) and Pfizer (NYSE: PFE), makers of two of the three coronavirus vaccines authorized for use in the U.S., both outpaced the sagging S&P 500 index on Thursday. Moderna stock fell less precipitously than the closely watched index, sliding by 0.4%, while Pfizer rose more than 4% on the day. A key catalyst for both was the latest vaccine recommendation from a top healthcare authority.
On Thursday, an influential committee advising the Centers For Disease Control and Prevention (CDC), voted to recommend two coronavirus vaccines be preferred for use. Johnson & Johnson's (NYSE: JNJ) shot was not one of them.
Image source: Getty Images.
Source Fool.com
